Nasal Mucosa

• 

  Subject Areas on Research

  • A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. 
  • A novel neurotoxoid vaccine prevents mucosal botulism. 
  • Abnormal ion permeation through cystic fibrosis respiratory epithelium. 
  • Alpha-adrenergic mRNA subtype expression in the human nasal turbinate. 
  • Beyond the nasoseptal flap: outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction. 
  • Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans. 
  • Characterization of potential precursor populations in the mouse olfactory epithelium using immunocytochemistry and autoradiography. 
  • Characterizing airflow profile in the postoperative maxillary sinus by using computational fluid dynamics modeling: A pilot study. 
  • Complications and solutions in presurgical nasoalveolar molding therapy. 
  • Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. 
  • Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. 
  • Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. 
  • Developmental change in unilateral olfactory habituation is mediated by anterior commissure maturation. 
  • Early-Life Intranasal Colonization with Nontypeable Haemophilus influenzae Exacerbates Juvenile Airway Disease in Mice. 
  • Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. 
  • Histology, ultrastructure, and carbohydrate cytochemistry of surface and glandular epithelium of human nasal mucosa. 
  • IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. 
  • In reference to Regional peak mucosal cooling predicts the perception of nasal patency. 
  • Influence of exposure to tobacco cigarette smoke on the eosinophil count in the nasal mucosa of young patients with perennial allergic rhinitis. 
  • Influenza research in the Soviet Union--1974. 
  • Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. 
  • Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro. 
  • Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara. 
  • Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. 
  • Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone. 
  • Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. 
  • Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals. 
  • Mucosal melanoma. 
  • Mucosal vaccine development for botulinum intoxication. 
  • Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. 
  • Nasal effects of a mixture of volatile organic compounds and their ozone oxidation products. 
  • Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia. 
  • Nasal toxicity of manganese sulfate and manganese phosphate in young male rats following subchronic (13-week) inhalation exposure. 
  • Nose blowing propels nasal fluid into the paranasal sinuses. 
  • Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. 
  • Novel role of surfactant protein A in bacterial sinusitis. 
  • Odorant receptors govern the formation of a precise topographic map. 
  • Perception of better nasal patency correlates with increased mucosal cooling after surgery for nasal obstruction. 
  • Presurgical columellar elongation and primary retrograde nasal reconstruction in one-stage bilateral cleft lip and nose repair. 
  • Real-time In Vitro Monitoring of Odorant Receptor Activation by an Odorant in the Vapor Phase. 
  • Real-time quantitative elemental analysis and mapping: microchemical imaging in cell physiology. 
  • Recovery of soil Amebas from the nasal passages of children during the dusty harmattan period in Zaria. 
  • Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. 
  • Response to Dr Chung's Question on Simulating the Nasal Cycle with Computational Fluid Dynamics. 
  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. 
  • Simulating the nasal cycle with computational fluid dynamics. 
  • Slime production, adherence and hydrophobicity in coagulase-negative staphylococci causing peritonitis in peritoneal dialysis. 
  • Spatial organisation of microbiota in quiescent adenoiditis and tonsillitis. 
  • Stable dry powder formulation for nasal delivery of anthrax vaccine. 
  • Synergistic effect of Epstein-Barr virus and tumor promoters on induction of lymphoma and carcinoma in nude mice. 
  • Transmission of methicillin-resistant Staphylococcus aureus between human and hamster. 
• 

  Keywords of People

  • Frank-Ito, Dennis Onyeka, Associate Professor in Head and Neck Surgery and Communication Sciences, Mechanical Engineering and Materials Science
  • Staats, Herman Ford, Professor of Pathology, Immunology